Results 221 to 230 of about 26,123,489 (353)
Where and when should a cancer vaccine be administered? A whole‐body PBPK model demonstrates that systemic immune transport critically determines vaccination efficacy. By simulating how organ‐specific immune interactions influence treatment response, the study provides a quantitative framework for optimizing cancer vaccination strategies.
Mohammad R. Nikmaneshi +2 more
wiley +1 more source
Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction. [PDF]
Brlek P +4 more
europepmc +1 more source
Vaccination promotes cellular infiltration into primary lesions and effectively inhibits T. pallidum dissemination to distal organs. Notably, transfer of lesion tissue from immunized animals fails to establish infection in naive recipients, confirming specific protective immunity.
Yinbo Jiang +4 more
wiley +1 more source
Flipping the script: Using mucosal immune obstacles to inform vaccine design. [PDF]
Antia A, Ding S.
europepmc +1 more source
An Integrated Artificial Intelligence Framework for Nanomedicine Engineering
This review outlines a closed‐loop AI ecosystem for nanomedicine engineering. By synergizing multimodal data harmonization, objective‐driven AI architectures, and automated high‐throughput validation, this “Design‐Make‐Test‐Analyze” (DMTA) workflow transforms traditional heuristic formulation into a predictive, self‐optimizing paradigm, accelerating ...
Meichen Dong +10 more
wiley +1 more source
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design. [PDF]
Skelly AN +57 more
europepmc +1 more source
Hydrogel‐forming microneedle (HFMN)‐reservoir patches provide a modular route for controlled transdermal delivery of hydrophilic biomacromolecules. The platform integrates skin‐barrier penetration, sustainable biopolymers, scalable green manufacturing, hydration‐driven transport, model‐cargo validation, and translational quality requirements.
Siddharth Mohanty +4 more
wiley +1 more source
SARS-CoV-2 Variants and Immune Evasion: Mapping the Future of Vaccine Design. [PDF]
Uzer F, Erendor F, Sanlioglu S.
europepmc +1 more source
A biomimetic platelet nanoplatform (OE‐ACAD11@R‐PLT) is developed for targeted hepatocellular carcinoma immunotherapy. By selectively delivering therapeutic plasmids, this system induces mitochondrial dysfunction and triggers robust NLRP3/Caspase‐1/GSDMD‐mediated pyroptosis in tumor cells.
Hongyi Bao +12 more
wiley +1 more source
GC B Cells, Tfh Cells, and Influenza bnAbs: Insights for Improving Universal Vaccine Design. [PDF]
Inoue T, Ise W, Kurosaki T.
europepmc +1 more source

